Egyptian Drug Authority · Egypt
DEA-EG-2022-0017
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(17) For 2022
- Date issued
- 30 May 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- TobraDex Eye drops
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 21D30IA
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
٠٣ مايو ٢٢٠٢
حيث أفادت شـــركة نوفارتـــس أن المســـتحضر المدون عليه
تلك التشغيلة لايخص الشركة ولم تقم بتصنيعه وعليه فإن
العبوات مقلدة ومغشوشة.
يتم ضبط وتحريز العبوات المقلدة والمغشوشة من
المستحضر التالي:
منشور
غش تجاري
TobraDex eye drops
إستيراد :الشركة المصرية السويسرية
لصالح : نوفارتس
21D30IA رقم التشغيلة
TobraDex
Eye DropsOriginal language: ar
- Notice text in English
- Trade-counterfeiting circular, May 2022. Counterfeit and adulterated packs of the following product are to be impounded and seized: TobraDex eye drops, batch number 21D30IA, imported by the Egyptian Swiss Company on behalf of Novartis. Novartis has stated that the product bearing that batch number is not theirs and was not manufactured by them, so the packs are counterfeit and adulterated.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 6f64dcfcee01bd019a859e301daee27df155fd686a226058c7d0a48ff04a1227SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:35:57 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0017: TobraDex Eye drops — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0017Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.